SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-098668
Filing Date
2023-09-06
Accepted
2023-09-06 16:40:33
Documents
12
Period of Report
2023-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2325511d1_8k.htm   iXBRL 8-K 23722
  Complete submission text file 0001104659-23-098668.txt   196155

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hepa-20230830.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20230830_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20230830_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2325511d1_8k_htm.xml XML 3293
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 231239740
SIC: 2834 Pharmaceutical Preparations